Skip to main content
. 2023 May 19;23:463. doi: 10.1186/s12885-023-10768-8

Table 3.

Summary of adverse events

Events, n (%) All patients (n = 40)
Any grade Grade 3
Hypertension 26 (65.0%) 2 (5.0%)
Nausea 19 (47.5%) 0
Vomiting 17 (42.5%) 0
Hand-foot syndrome 13 (32.5%) 0
Abdominal pain 11 (27.5%) 0
White blood cell count decreased 9 (22.5%) 0
Fatigue 7 (17.5%) 0
Skin ulceration 6 (15.0%) 0
Gingival hemorrhaging or pain 6 (15.0%) 0
Proteinuria 4 (10.0%) 2 (5.0%)
Anorexia 4 (10.0%) 0
Alopecia 3 (7.5%) 0
Fever 1 (2.5%) 0